NIH-funded research Fellowship grant

Investigating how a protein affects lung function during mechanical ventilation

Official title: Post-Translational Modification of Annexin A2 Mediates Surfactant Dysfunction During Injurious Mechanical Ventilation

Funded at Ohio State University · NIH-10998167 · Data updated 2026-11-12

This study is looking at how a protein changes when patients with acute respiratory distress syndrome (ARDS) are on mechanical ventilation, and how these changes might affect lung function, with the hope of finding better treatments to help ARDS patients breathe easier.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startDecember 1, 2024
Project endNovember 30, 2026
Funding year2024
Award (this year)$86,932
NIH project number1F32HL176082-01
Project IDNIH-10998167 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with acute respiratory distress syndrome who require mechanical ventilation.

Less likely to help

Patients with chronic respiratory conditions or those not requiring mechanical ventilation may not benefit from this research.

What this research studies

This research focuses on understanding how a specific protein, annexin A2, is modified during mechanical ventilation, which is often necessary for patients with acute respiratory distress syndrome (ARDS). The study aims to explore how these modifications lead to dysfunction in pulmonary surfactant, a substance crucial for proper lung function. Using both animal models and innovative human-based technology, the research will examine the mechanisms behind this dysfunction and seek to identify potential new treatment targets. The ultimate goal is to improve outcomes for patients suffering from ARDS by mitigating the harmful effects of mechanical ventilation.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve lung function and survival rates for patients with ARDS.

How similar studies have gone: Previous research has shown promising results in understanding surfactant dysfunction in ARDS, but this specific approach using annexin A2 is novel.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Bentley, Ian — Ohio State University
  • Study coordinator: Bentley, Ian

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.